Needham & Company LLC Issues Positive Forecast for Synopsys (NASDAQ:SNPS) Stock Price

Synopsys (NASDAQ:SNPS – Free Report) had its price target upped by Needham & Company LLC from $580.00 to $620.00 in a report published on Monday, Marketbeat reports. The brokerage currently has a buy rating on the semiconductor company’s stock.

A number of other brokerages have also recently issued reports on SNPS. JPMorgan Chase & Co. decreased their price objective on shares of Synopsys from $650.00 to $600.00 in a report on Thursday, August 27th. Mizuho cut their target price on shares of Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a report on Thursday, August 27th. Zacks Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 2nd. BNP Paribas Exane lifted their price target on shares of Synopsys from $420.00 to $475.00 and gave the stock a “neutral” rating in a research report on Thursday, October 1st. Finally, Morgan Stanley decreased their price target on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a report on Wednesday, August 19th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $571.78.

Get Our Latest Stock Analysis on SNPS

Synopsys Stock Down 1.5%

Shares of Synopsys stock opened at $502.51 on Monday. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. Synopsys has a 12 month low of $362.55 and a 12 month high of $539.48. The business has a fifty day simple moving average of $422.15 and a 200 day simple moving average of $439.66. The stock has a market cap of $96.30 billion, a PE ratio of 88.78, a price-to-earnings-growth ratio of 2.08 and a beta of 1.21.

Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company’s revenue was up 42.4% compared to the same quarter last year. During the same quarter last year, the business earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Research analysts predict that Synopsys will post 10.97 EPS for the current year.

Synopsys announced that its Board of Directors has initiated a share buyback plan on Monday, October 5th that permits the company to buy back $1.00 billion in outstanding shares. This repurchase authorization permits the semiconductor company to reacquire up to 1.1% of its stock through open market purchases. Share repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Insider Transactions at Synopsys

In other Synopsys news, insider Aart de Geus sold 24,641 shares of the company’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the completion of the transaction, the insider owned 120,443 shares of the company’s stock, valued at $50,518,611.92. This represents a 16.98% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,604 shares of Synopsys stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the completion of the sale, the chief executive officer owned 76,865 shares in the company, valued at $28,815,151.20. This trade represents a 15.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 102,559 shares of company stock worth $44,607,141. 0.56% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Synopsys

Large investors have recently modified their holdings of the business. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Synopsys during the 2nd quarter worth about $747,400,000. Man Group plc bought a new stake in shares of Synopsys during the 2nd quarter worth about $55,900,000. Nykredit A S bought a new stake in shares of Synopsys during the 2nd quarter worth about $23,158,000. Bank of America Corp DE acquired a new position in Synopsys in the 2nd quarter valued at about $539,986,000. Finally, Integrated Wealth Concepts LLC grew its stake in Synopsys by 88.6% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 6,816 shares of the semiconductor company’s stock valued at $3,040,000 after buying an additional 3,202 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.

About Synopsys

(Get Free Report)

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.

Further Reading

Analyst Recommendations for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.